Dr Pablo Fernandez is a consultant pharmaceutical physician. Having worked initially in Medical Oncology, Dr Fernandez joined the pharmaceutical Industry in 1979 and has headed international clinical research departments for a number of companies: Cyanamid/Lederle, Wyeth, Wellcome, Bayer and PharmaNet, a global Contract Research Organisation that specialises in clinical drug development.
During this time, he specialised in the clinical development of new medicines, becoming a Member in 1989 of the newly formed Faculty of Pharmaceutical Medicine (FPM) of the UK Royal Colleges of Physicians and then a Fellow of that Faculty in 1997. He was elected to the FPM Board in 2003 and 2005 and now serves as an Officer of the FPM Board of Examiners, as well as the Panel Convenor for quality management of accredited courses for the Clinical Development module of the Pharmaceutical Medicine Specialty Training syllabus. He is also involved in the preparation of the Faculty’s revalidation system for Pharmaceutical Physicians.
Dr Fernandez was a long-standing member of the Association of the British Pharmaceutical Industry’s Medical Committee and its successor bodies, the Medical Experts Network and the Clinical Research Experts Network. In that capacity he was closely involved in the initiatives that resulted in the voluntary registration. Industry-sponsored clinical trials in a publicly accessible website.
Competing Interest Disclosure statement for Dr Pablo Fernandez in 2021.